MASTERINVEST Kapitalanlage GmbH Purchases Shares of 8,838 Danaher Corporation $DHR

MASTERINVEST Kapitalanlage GmbH acquired a new stake in shares of Danaher Corporation (NYSE:DHR) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 8,838 shares of the conglomerate’s stock, valued at approximately $1,746,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Thompson Davis & CO. Inc. bought a new stake in Danaher in the 2nd quarter valued at about $244,000. B. Riley Wealth Advisors Inc. acquired a new stake in Danaher in the second quarter valued at approximately $574,000. Marex Group plc acquired a new stake in Danaher in the second quarter valued at approximately $3,124,000. Anchor Investment Management LLC raised its position in shares of Danaher by 3.8% during the second quarter. Anchor Investment Management LLC now owns 8,931 shares of the conglomerate’s stock worth $1,764,000 after purchasing an additional 324 shares during the period. Finally, Asset Dedication LLC raised its position in shares of Danaher by 6.8% during the second quarter. Asset Dedication LLC now owns 3,634 shares of the conglomerate’s stock worth $718,000 after purchasing an additional 232 shares during the period. Institutional investors own 79.05% of the company’s stock.

Insider Buying and Selling

In other Danaher news, SVP Georgeann Couchara sold 5,174 shares of the business’s stock in a transaction dated Monday, November 10th. The shares were sold at an average price of $210.42, for a total value of $1,088,713.08. Following the transaction, the senior vice president directly owned 2,625 shares in the company, valued at $552,352.50. The trade was a 66.34% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Teri List sold 3,298 shares of the stock in a transaction that occurred on Tuesday, November 18th. The shares were sold at an average price of $226.50, for a total transaction of $746,997.00. Following the transaction, the director directly owned 20,762 shares of the company’s stock, valued at $4,702,593. This represents a 13.71% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 30,248 shares of company stock valued at $6,609,663. 11.20% of the stock is owned by insiders.

Analysts Set New Price Targets

Several research firms recently issued reports on DHR. Weiss Ratings reissued a “hold (c-)” rating on shares of Danaher in a research report on Wednesday, October 8th. HSBC lifted their price objective on shares of Danaher from $255.00 to $270.00 and gave the company a “buy” rating in a report on Monday, December 1st. Royal Bank Of Canada set a $241.00 target price on shares of Danaher in a report on Tuesday, September 2nd. Deutsche Bank Aktiengesellschaft raised their price target on shares of Danaher from $235.00 to $250.00 and gave the company a “buy” rating in a research report on Wednesday, October 22nd. Finally, Cowen reissued a “buy” rating on shares of Danaher in a research note on Wednesday, October 22nd. Twenty-one investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $246.79.

Danaher Price Performance

Danaher stock opened at $226.70 on Monday. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $258.23. The company’s 50 day moving average price is $218.51 and its two-hundred day moving average price is $205.90. The stock has a market cap of $160.13 billion, a P/E ratio of 46.74, a P/E/G ratio of 4.39 and a beta of 0.89. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Monday, October 20th. The conglomerate reported $1.89 EPS for the quarter, beating analysts’ consensus estimates of $1.72 by $0.17. The company had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $6 billion. Danaher had a return on equity of 10.92% and a net margin of 14.44%.Danaher’s revenue was up 4.4% on a year-over-year basis. During the same period last year, the business posted $1.71 earnings per share. On average, equities analysts predict that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Friday, December 26th will be paid a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date is Friday, December 26th. Danaher’s payout ratio is presently 26.39%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.